• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY VASCULAR CATHETER; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES, PR FOGARTY ARTERIAL EMBOLECTOMY VASCULAR CATHETER; CATHETER, EMBOLECTOMY Back to Search Results
Model Number 120804F
Device Problem Detachment of Device or Device Component (2907)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/17/2024
Event Type  Injury  
Manufacturer Narrative
The product is expected to be returned for analysis; however, it has not yet been received.Upon the return of the product a supplemental report will be sent with the investigation results.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Event Description
As reported, after a successful first insertion of this fogarty embolectomy catheter, the device was inserted again into the patient and the balloon detached and remained inside patient.An ultrasonographic tracking and extension of the incision was done to retrieve the detached balloon.
 
Manufacturer Narrative
Updated: d9 (device availability), h3 (device evaluated by manufacturer), h6 (investigation findings, investigation conclusions).Added: h6 (type of investigation).The fogarty catheter was not received at our product evaluation laboratory for evaluation.Therefore, a product non-conformance or device failure associated to manufacturing or design could not be confirmed.The manufacturing records were reviewed and there is no indication of a related nonconformance; all process parameters were met, and inspections passed successfully.As part of the manufacturing process a 100% of the units go through a balloon winding and full visual inspection process.Instructions for use provides warnings and cautions related to the balloon and the handling of the catheter as a guideline to follow: "balloon rupture and catheter separation as a result of excessive pull force applied to remove adherent material are the most frequent causes of reported failures.The possibility of balloon rupture must be taken into account when considering the risks involved in any embolectomy procedure" and "to minimize the risk of vessel damage, balloon rupture, or tip detachment, do not exceed the maximum recommended inflation volume and pull force for each size catheter".Since the affected unit was not returned for evaluation, a product non-conformance or device failure could not be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FOGARTY ARTERIAL EMBOLECTOMY VASCULAR CATHETER
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco
Manufacturer (Section G)
EDWARDS LIFESCIENCES, PR
state rd indus pk 402 km 1.4
anasco
Manufacturer Contact
samantha eveleigh
1 edwards way
irvine, CA 92614
9492503939
MDR Report Key18987772
MDR Text Key338725361
Report Number2015691-2024-02346
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K193379
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number120804F
Device Lot Number64577753
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/05/2024
Initial Date FDA Received03/27/2024
Supplement Dates Manufacturer Received04/30/2024
Supplement Dates FDA Received05/03/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/21/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age35 YR
Patient SexFemale
Patient Weight75 KG
-
-